# Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions

> **NCT02322645** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 46 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Eszopiclone Tablets 3 mg

## Key facts

- **NCT ID:** NCT02322645
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-08
- **Final completion:** 2008-10
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2014-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02322645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02322645, "Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02322645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*